Heritage Wealth Advisors’s Co-Diagnostics CODX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$32 Sell
17
-1
-6% -$3 ﹤0.01% 670
2025
Q4
$89 Hold
18
﹤0.01% 579
2025
Q3
$181 Hold
18
﹤0.01% 568
2025
Q2
$147 Hold
18
﹤0.01% 557
2025
Q1
$163 Hold
18
﹤0.01% 560
2024
Q4
$394 Hold
18
﹤0.01% 603
2024
Q3
$656 Hold
18
﹤0.01% 582
2024
Q2
$656 Hold
18
﹤0.01% 492
2024
Q1
$588 Hold
18
﹤0.01% 513
2023
Q4
$698 Hold
18
﹤0.01% 521
2023
Q3
$557 Hold
18
﹤0.01% 484
2023
Q2
$583 Hold
18
﹤0.01% 524
2023
Q1
$777 Hold
18
﹤0.01% 536
2022
Q4
$1.32K Hold
18
﹤0.01% 515
2022
Q3
$1.69K Hold
18
﹤0.01% 486
2022
Q2
$3K Hold
18
﹤0.01% 509
2022
Q1
$3K Hold
18
﹤0.01% 487
2021
Q4
$5K Hold
18
﹤0.01% 480
2021
Q3
$5.11K Hold
18
﹤0.01% 473
2021
Q2
$4.33K Hold
18
﹤0.01% 492
2021
Q1
$5.01K Hold
18
﹤0.01% 496
2020
Q4
$5K Hold
18
﹤0.01% 486
2020
Q3
$7.13K Hold
18
﹤0.01% 410
2020
Q2
$10.2K Hold
18
﹤0.01% 381
2020
Q1
$4K Buy
+18
New +$3.12K ﹤0.01% 404

Other funds holding CODX

Heritage Wealth Advisors's CODX Position: Q1 2026 in Review

Heritage Wealth Advisors reduced its Co-Diagnostics (CODX) stake by 5.6% in Q1 2026, selling an estimated $3 and leaving 17 shares worth $32. The position accounts for ﹤0.01% of the portfolio, ranked #670.

Heritage Wealth Advisors first reported a position in CODX in Q1 2020 and has held it in 25 quarters since. The position peaked at $10.2K in Q2 2020. 14 funds tracked by Wall St. Rank hold CODX as of Q1 2026.

  • Heritage Wealth Advisors held 17 shares of Co-Diagnostics worth $32 as of Q1 2026.
  • Heritage Wealth Advisors sold 1 Co-Diagnostics share in Q1 2026, an estimated $3.
  • Co-Diagnostics made up ﹤0.01% of Heritage Wealth Advisors's portfolio in Q1 2026, its #670 holding.
  • Heritage Wealth Advisors first reported a position in Co-Diagnostics in Q1 2020 and has held it in 25 quarters since.
  • Heritage Wealth Advisors's Co-Diagnostics position peaked at $10.2K in Q2 2020.
  • 14 funds tracked by Wall St. Rank held Co-Diagnostics as of Q1 2026.

Based on Heritage Wealth Advisors's 13F filing for Q1 2026, filed 14 May 2026.